Neuritogenic actions of botulinum neurotoxin A on cultured motor neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 1, 2009, Pages 352-358

  Coffield, Julie A ^a   Yan, Xiuzhen ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; LECTIN; NEUROTOXIN; SNARE PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; IMMUNOBLOTTING; MOTONEURON; MOUSE; NERVE CELL CULTURE; NERVE FIBER GROWTH; NEUROMUSCULAR BLOCKING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; TOXIN ANALYSIS; WHEAT;

ANIMALS; BOTULINUM TOXIN TYPE A; CELLS, CULTURED; CYTOPLASMIC VESICLES; EMBRYONIC STEM CELLS; FEMALE; INTRACELLULAR FLUID; MICE; MOTOR NEURONS; NEURITES; NEUROGENESIS; PREGNANCY; SIGNAL TRANSDUCTION;

EID: 67649866052     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.147744     Document Type: Article

References (40)

1. Ahnert-Hilger G, Höltje M, Grosse G, Pickert G, Mucke C, Nixdorf-Bergweiler B, Boquet P, Hofmann F, and Just I (2004) Differential effects of rho GTPases on axonal and dendritic development in hippocampal neurones. J Neurochem 90:9-18. (Pubitemid 38879157)
2. Anderson KN, Potter AC, Piccenna LG, Quah AK, Davies KE, and Cheema SS (2004) Isolation and culture of motor neurons from the newborn mouse spinal cord. Brain Res Brain Res Protoc 12:132-136. (Pubitemid 38316792)
3. Angaut-Petit D, Molgó J, Comella JX, Faille L, and Tabti N (1990) Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 37:799-808. (Pubitemid 20282217)
4. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, et al. (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059-1070. (Pubitemid 32176420)
5. Bakry N, Kamata Y, and Simpson LL (1991) Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. J Pharmacol Exp Ther 258:830-836.
6. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Südhof TC, Niemann H, and Jahn R (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160-163. (Pubitemid 23282061)
7. Bonner PH, Friedli AF, and Baker RS (1994) Botulinum A toxin stimulates neurite branching in nerve-muscle cocultures. Brain Res Dev Brain Res 79:39-46. (Pubitemid 24151809)
8. Booth CM, Kemplay SK, and Brown MC (1990) An antibody to neural cell adhesion molecule impairs motor nerve terminal sprouting in a mouse muscle locally paralysed with botulinum toxin. Neuroscience 35:85-91. (Pubitemid 20113971)
9. Calabrese EJ (2008) Enhancing and regulating neurite outgrowth. Crit Rev Toxicol 38:391-418.
10. Caroni P, Schneider C, Kiefer MC, and Zapf J (1994) Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. J Cell Biol 125:893-902. (Pubitemid 24151183)
11. Coffield JA, Considine RV, Jeyapaul J, Maksymowych AB, Zhang RD, and Simpson LL (1994) The role of transglutaminase in the mechanism of action of tetanus toxin. J Biol Chem 269:24454-24458. (Pubitemid 24300997)
12. Comella JX, Molgo J, and Faille L (1993) Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions. Neurosci Lett 153:61-64. (Pubitemid 23147037)
13. DasGupta BR (1989) The structure of botulinum neurotoxin, in Botulinum Neurotoxin and Tetanus Toxin (Simpson LL ed) pp 53-67, Academic Press, New York.
14. de Paiva A, Meunier FA, Molgó J, Aoki KR, and Dolly JO (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96:3200-3205.
15. Diaz J, Molgó J, and Pécot-Dechavassine M (1989) Sprouting of frog motor nerve terminals after long-term paralysis by botulinum type A toxin. Neurosci Lett 96:127-132. (Pubitemid 19023469)
16. Erbguth FJ (2008) From poison to remedy: the chequered history of botulinum toxin. J Neural Transm 115:559-565.
17. Holds JB, Alderson K, Fogg SG, and Anderson RL (1990) Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci 31:964-967. (Pubitemid 20186110)
18. Holland RL and Brown MC (1981) Nerve growth in botulinum toxin poisoned muscles. Neuroscience 6:1167-1179. (Pubitemid 11064221)
19. Hopkins WG, Brown MC, and Keynes RJ (1981) Nerve growth from nodes of Ranvier in inactive muscle. Brain Res 222:125-128. (Pubitemid 11059706)
20. Igarashi M, Kozaki S, Terakawa S, Kawano S, Ide C, and Komiya Y (1996) Growth cone collapse and inhibition of neurite growth by Botulinum neurotoxin C1: a t-SNARE is involved in axonal growth. J Cell Biol 134:205-215. (Pubitemid 26231531)
21. Ishida H, Zhang X, Erickson K, and Ray P (2004) Botulinum toxin type A targets RhoB to inhibit lysophosphatidic acid-stimulated actin reorganization and acetylcholine release in nerve growth factor-treated PC12 cells. J Pharmacol Exp Ther 310:881-889. (Pubitemid 39108907)
22. Jankovic J (2004) Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 75:951-957.
23. Juzans P, Comella JX, Molgo J, Faille L, and Angaut-Petit D (1996) Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromuscul Disord 6:177-185. (Pubitemid 26171260)
24. Kalandakanond S and Coffield JA (2001a) Cleavage of intracellular substrates of botulinum toxins A, C, and D in a mammalian target tissue. J Pharmacol Exp Ther 296:749-755. (Pubitemid 32187343)
25. Kalandakanond S and Coffield JA (2001b) Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc. J Pharmacol Exp Ther 296:980-986. (Pubitemid 32187373)
26. Kimura K, Mizoguchi A, and Ide C (2003) Regulation of growth cone extension by SNARE proteins. J Histochem Cytochem 51:429-433. (Pubitemid 36418039)
27. Kozaki S, Kamata Y, Watarai S, Nishiki T, and Mochida S (1998) Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. Microb Pathog 25:91-99. (Pubitemid 28398979)
28. Kozaki S, Togashi S, and Sakaguchi G (1981) Separation of Clostridium botulinum type A derivative toxin into two fragments. Jpn J Med Sci Biol 34:61-68. (Pubitemid 11012237)
29. Ledeen RW and Wu G (2002) Ganglioside function in calcium homeostasis and signaling. Neurochem Res 27:637-647.
30. Lee RE, Tartell PB, Karmody CS, and Hunter DD (1999) Association of adhesive macromolecules with terminal sprouts at the neuromuscular junction after botulinum treatment. Otolaryngol Head Neck Surg 120:255-261. (Pubitemid 29077540)
31. Meunier FA, Lisk G, Sesardic D, and Dolly JO (2003) Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation. Mol Cell Neurosci 22:454-466. (Pubitemid 36513569)
32. Montecucco C (1986) How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci 11:314-317.
33. Montecucco C, Rossetto O, and Schiavo G (2004) Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol 12:442-446. (Pubitemid 39286121)
34. Morihara T, Mizoguchi A, Takahashi M, Kozaki S, Tsujihara T, Kawano S, Shirasu M, Ohmukai T, Kitada M, Kimura K, et al. (1999) Distribution of synaptosomalassociated protein 25 in nerve growth cones and reduction of neurite outgrowth by botulinum neurotoxin A without altering growth cone morphology in dorsal root ganglion neurons and PC-12 cells. Neuroscience 91:695-706. (Pubitemid 29193278)
35. Osen-Sand A, Staple JK, Naldi E, Schiavo G, Rossetto O, Petitpierre S, Malgaroli A, Montecucco C, and Catsicas S (1996) Common and distinct fusion proteins in axonal growth and transmitter release. J Comp Neurol 367:222-234. (Pubitemid 26107113)
36. Pamphlett R (1989) Early terminal and nodal sprouting of motor axons after botulinum toxin. J Neurol Sci 92:181-192. (Pubitemid 19241803)
37. Schä fer R and Wernig A (1998) Polyclonal antibodies against NCAM reduce paralysis- induced axonal sprouting. J Neurocytol 27:615-624.
38. Schiavo G, Matteoli M, and Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80:717-766.
39. Schiavo G, Rossetto O, Catsicas S, Polverino de Laureto P, DasGupta BR, Benfenati F, and Montecucco C (1993) Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem 268:23784-23787. (Pubitemid 23335346)
40. Vogelsgesang M, Pautsch A, and Aktories K (2007) C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins. Naunyn Schmiedebergs Arch Pharmacol 374:347-360. (Pubitemid 46215285)